Dexcom, the local maker of continuous glucose monitors, received a warning letter from the Food and Drug Administration last ...
DXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising ...
GlobalData on MSN7d
Analysts say Dexcom’s FDA warning unlikely to impact 2025 revenueDexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...
Dexcom announced today that it received a warning letter from the FDA following inspections of two company facilities.
DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.
Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...
The warning letter follows inspections by the FDA at Dexcom’s manufacturing facilities in San Diego and Mesa, Ariz., and identified concerns in manufacturing processes and quality management.
DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback